These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 3570029

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
    Morgan MY, Hawley KE.
    Hepatology; 1987; 7(6):1278-84. PubMed ID: 3315932
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
    Fehér J, Prónai L.
    Orv Hetil; 1993 Jun 27; 134(26):1417-9. PubMed ID: 8332363
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
    Morgan MY, Alonso M, Stanger LC.
    J Hepatol; 1989 Mar 27; 8(2):208-17. PubMed ID: 2654285
    [Abstract] [Full Text] [Related]

  • 9. Nonabsorbable disaccharides for hepatic encephalopathy.
    Als-Nielsen B, Gluud LL, Gluud C.
    Cochrane Database Syst Rev; 2004 Mar 27; (2):CD003044. PubMed ID: 15106187
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.
    Heredia D, Caballería J, Arroyo V, Ravelli G, Rodés J.
    J Hepatol; 1987 Jun 27; 4(3):293-8. PubMed ID: 3598162
    [Abstract] [Full Text] [Related]

  • 12. [Lactitol and neomycin: monotherapy or combined therapy in the prevention and treatment of hepatic encephalopathy?].
    Scevola D, Zambelli A, Concia E, Perversi L, Candiani C.
    Clin Ter; 1989 Apr 30; 129(2):105-11. PubMed ID: 2525995
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.
    Cammà C, Fiorello F, Tinè F, Marchesini G, Fabbri A, Pagliaro L.
    Dig Dis Sci; 1993 May 30; 38(5):916-22. PubMed ID: 8482191
    [Abstract] [Full Text] [Related]

  • 15. Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis.
    Blanc P, Daures JP, Rouillon JM, Peray P, Pierrugues R, Larrey D, Gremy F, Michel H.
    Hepatology; 1992 Feb 30; 15(2):222-8. PubMed ID: 1531204
    [Abstract] [Full Text] [Related]

  • 16. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
    Morgan MY.
    Metab Brain Dis; 2016 Dec 30; 31(6):1361-1364. PubMed ID: 27638474
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disaccharides in the treatment of hepatic encephalopathy.
    Sharma P, Sharma BC.
    Metab Brain Dis; 2013 Jun 30; 28(2):313-20. PubMed ID: 23456517
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients].
    Grandi M, Sacchetti C, Pederzoli S, Celani MF.
    Minerva Gastroenterol Dietol; 1991 Jun 30; 37(4):225-30. PubMed ID: 1805974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.